8-K current report · filed Sep 25, 2026

Aquestive Therapeutics, Inc. (AQST) 8-K Current Report: September 25, 2026

Item 7.01AQST overview

Short answer

Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on September 25, 2026 reporting Item 7.01 (Regulation FD Disclosure). Investor presentation disclosed to institutional investors, analysts and other market participants.

Aquestive Therapeutics, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Investor presentation disclosed to institutional investors, analysts and other market participants
  • Presentation likely outlines AQST’s business outlook, pipeline and strategy, with substantive details in Exhibit 99.1
  • Potentially market-moving updates available through the company’s investor-relations website and future filings

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Aquestive Therapeutics, Inc. 8-K filings

Get the next AQST 8-K as it lands

Follow AQST for push alerts, or ask the research agent what this filing means.